Don't miss Katayoun Rezvani's their talk on off-the-shelf NK cell therapies #AACR26. This recent study employs CD70-targeting #CAR_NK Cells to overcome BCMA downregulation, improving survival in #MultipleMyeloma models. https://t.co/nfCUSWh2MT @lab_rezvani #MMsm https://t.co/2YkP4wYG7M